Lipobay en es it fr

Lipobay Brand names, Lipobay Analogs

Lipobay Brand Names Mixture

  • No information avaliable

Lipobay Chemical_Formula


Lipobay RX_link

Lipobay fda sheet

Lipobay FDA

Lipobay msds (material safety sheet)

Lipobay Synthesis Reference

Angerbauer R, Bischoff H, Steinke W and Ritter W (1994) BAY w 6228. Drugs Fut 19: 537-541.

Lipobay Molecular Weight

459.55 g/mol

Lipobay Melting Point

No information avaliable

Lipobay H2O Solubility

Highly solubility

Lipobay State


Lipobay LogP


Lipobay Dosage Forms


Lipobay Indication

Used as an adjunct to diet for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate.

Lipobay Pharmacology

Cerivastatin, a competitive HMG-CoA reductase inhibitor effective in lowering LDL cholesterol and triglycerides, is used to treat primary hypercholesterolemia and mixed dyslipidemia (Fredrickson types IIa and IIb).

Lipobay Absorption

The mean absolute oral bioavailability 60% (range 39 - 101%).

Lipobay side effects and Toxicity

Rhabdomyolysis, liver concerns

Lipobay Patient Information

Patients should be advised to report promptly unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever.

Lipobay Organisms Affected

Humans and other mammals